Skip to main content

Table 1 Population characteristics

From: Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation – initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization

Age

63 ± 10yo

Gender (% male)

31% (12)

Known CAD

56% (22)

Pulmonary Hypertension

51% (20)

Atherosclerosis Risk Factors

Tobacco Use (prior or current)

46% (18)

Hypertension

67% (26)

Hyperlipidemia

54% (21)

Diabetes mellitus

18% (7)

Medication Regimen

ACE Inhibitors or ARB

51% (20)

Beta-Blockers

72% (28)

Aspirin

74% (29)

Statin

69% (27)

Diuretic

46% (18)

Cardiac Structure/Function

LVEF (%)

49 ± 14%

LV Dysfunction (EF < 50%)

49% (19)

LV End-Diastolic Volume

186 ± 57 ml

LV End-Systolic Volume

106 ± 56 ml

RV EF (%)

51 ± 11%

RV Dysfunction (EF < 50%)

31% (12)

RV End-Diastolic Volume

169 ± 62 ml

RV End-Systolic Volume

96 ± 52 ml

  1. Data reported as % (n) for categorical variables, mean standard deviation for continuous variables
  2. ACE angiotensin converting enzyme, ARB angiotensin receptor blocker, CAD coronary artery disease, EF ejection fraction, LV left ventricle, RV right ventricular